New Antidiabetic Agents Study Findings Have Been Reported by a Researcher at Hospital of Chengdu University of Traditional Chinese Medicine (Bibliometrics and visual analysis of metformin and gut microbiota from 2012 to 2022: A systematic review).

A recent study conducted by researchers at the Hospital of Chengdu University of Traditional Chinese Medicine in Chengdu, China, analyzed the research status and trends in the field of metformin and gut microbiota. The study used bibliometric tools to analyze publications from 2012 to 2022 and found that the number of research articles on this topic has been increasing annually. The study included 517 papers from 57 countries and identified China as the leading country in terms of publications. The most influential institution was the Chinese Academy of Sciences, and the most popular journal was PLOS ONE. The study also highlighted emerging topics such as "metabolites," "aging," and "intestinal barrier." The researchers concluded that their study provides new research topics and trends for studying the effects of metformin on gut microbiota in different diseases. [Extracted from the article]